These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 28138694

  • 1. Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
    Qiu XH, Li F, Cao HQ, Shao JJ, Mei JG, Li HQ, Zhai YP.
    Mol Med Rep; 2017 Mar; 15(3):1024-1030. PubMed ID: 28138694
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
    Landberg N, Dreimane A, Rissler M, Billström R, Ågerstam H.
    Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
    [Abstract] [Full Text] [Related]

  • 4. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
    Chase A, Grand FH, Cross NC.
    Blood; 2007 Nov 15; 110(10):3729-34. PubMed ID: 17698633
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.
    Kähkönen TE, Toriseva M, Petruk N, Virta AR, Maher A, Eigéliené N, Kaivola J, Boström P, Koskivuo I, Nees M, Tuomela JM, Ivaska KK, Härkönen PL.
    Cell Oncol (Dordr); 2021 Feb 15; 44(1):205-218. PubMed ID: 33119860
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Li F, Zhai YP, Tang YM, Wang LP, Wan PJ.
    Genes Chromosomes Cancer; 2012 Sep 15; 51(9):890-7. PubMed ID: 22619110
    [Abstract] [Full Text] [Related]

  • 10. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
    Feng S, Shao L, Castro P, Coleman I, Nelson PS, Smith PD, Davies BR, Ittmann M.
    Oncotarget; 2017 Jan 24; 8(4):6179-6192. PubMed ID: 28008155
    [Abstract] [Full Text] [Related]

  • 11. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.
    Chase A, Bryant C, Score J, Cross NC.
    Haematologica; 2013 Jan 24; 98(1):103-6. PubMed ID: 22875613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.
    Ren M, Hong M, Liu G, Wang H, Patel V, Biddinger P, Silva J, Cowell J, Hao Z.
    Oncol Rep; 2013 Jun 24; 29(6):2181-90. PubMed ID: 23563700
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biophysical characterization of drug-resistant mutants of fibroblast growth factor receptor 1.
    Yoza K, Himeno R, Amano S, Kobashigawa Y, Amemiya S, Fukuda N, Kumeta H, Morioka H, Inagaki F.
    Genes Cells; 2016 Oct 24; 21(10):1049-1058. PubMed ID: 27558949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).
    Wasag B, Lierman E, Meeus P, Cools J, Vandenberghe P.
    Haematologica; 2011 Jun 24; 96(6):922-6. PubMed ID: 21330321
    [Abstract] [Full Text] [Related]

  • 20. Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations.
    Fu W, Chen L, Wang Z, Kang Y, Wu C, Xia Q, Liu Z, Zhou J, Liang G, Cai Y.
    Phys Chem Chem Phys; 2017 Feb 01; 19(5):3649-3659. PubMed ID: 28094372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.